RESTRUCTURING (Detail Textuals) (Facility Elimination, USD $) In Millions, unless otherwise specified	3 Months Ended
Mar. 31, 2013
Restructuring Cost and Reserve [Line Items]
Restructuring period	20 months
Incremental expenses	$ 3.7
Capital expenditures	2.5
Scenario, Forecast
Restructuring Cost and Reserve [Line Items]
Description of restructuring plan	On May 8, 2013, our Board of Directors approved a restructuring of our vascular access manufacturing operations.
Incremental expenses	4.1
Capital expenditures	$ 2.7

Identifies the body or office that had the appropriate authority to approve the exit plan, and the date such approval was granted.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 146

-Paragraph 20

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Name:	us-gaap_RestructuringAndRelatedActivitiesAuthorizedApproval
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration